Gene · 55165
Papers1,450
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,450
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis Identifies Tumor Mutation Burden-associated Genes ASPM and KIF11 as Novel Biomarkers for Adrenocortical Carcinoma. | Curr Cancer Drug Targets | 2025 | 41178767 | PubTator, text mining | PubMed |
| Nodal Spread Prediction in Human Oral Tongue Squamous Cell Carcinoma Using a Cancer-Testis Antigen Genes Signature. | Int J Mol Sci | 2025 | 41009820 | PubTator, text mining | PubMed |
| Retraction: Expression of centrosomal protein 55 in glioma tissue and the influence on glioma cell functions. | Transl Cancer Res | 2025 | 40950673 | PubTator, text mining | PubMed |
| CEP55 Promotes Acral Melanoma Progression via MAPK Pathway and Predicts Survival Following Immunotherapy. | Oncol Res | 2025 | 40918457 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Prognostic Model Based on Cervical Cancer-Related Genes. | Reprod Sci | 2025 | 40908400 | PubTator, text mining | PubMed |
| Identification of endothelial INSR as an osteosarcoma-related biomarker and therapeutic target based on weighted gene co-expression network analysis. | Discov Oncol | 2025 | 40846806 | PubTator, text mining | PubMed |
| Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40826700 | PubTator, text mining | PubMed |
| Identification of immune escape-related prognostic genes and immune infiltration analysis in hepatocellular carcinoma based on bioinformatics. | Biochem Biophys Rep | 2025 | 40787250 | PubTator, text mining | PubMed |
| Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma. | Front Immunol | 2025 | 40771801 | PubTator, text mining | PubMed |
| A Risk Score Model Based on Drug-Sensitivity-Related Genes Has the Potential to Predict Oral Squamous Cell Carcinoma Prognosis. | Oral Health Prev Dent | 2025 | 40762677 | PubTator, text mining | PubMed |
| Identification of Novel Molecular Panel as Potential Biomarkers of PAN-Gastrointestinal Cancer Screening: Bioinformatics and Experimental Analysis. | Biology (Basel) | 2025 | 40723362 | PubTator, text mining | PubMed |
| MicroRNA Signatures in Lung Adenocarcinoma Metastases: Exploring the Oncogenic Targets of Tumor-Suppressive miR-195-5p and miR-195-3p. | Cancers (Basel) | 2025 | 40723231 | PubTator, text mining | PubMed |
| Cuproptosis-related gene CEP55 as a biomarker of pancreatic adenocarcinoma via multi-omics techniques and experimental validation. | Radiol Oncol | 2025 | 40677006 | PubTator, text mining | PubMed |
| Optical fiber-assisted enzymatic recombinase amplification: A label-free biosensing platform for ultrasensitive DNA detection. | Biosens Bioelectron | 2025 | 40664138 | PubTator, text mining | PubMed |
| Identification of biomarkers and exploration of mechanisms for atopic dermatitis based on transcriptome and scRNA-seq data analysis. | Medicine (Baltimore) | 2025 | 40629565 | PubTator, text mining | PubMed |
| In-silico analysis of CEP55/E2F1/hsa-let-7b-5p/TMPO-AS1 axis-based ceRNA network promoting poor prognosis in lung adenocarcinoma smokers. | Bioimpacts | 2025 | 40584906 | PubTator, text mining | PubMed |
| Machine learning-based prediction models for atopic dermatitis diagnosis and evaluation. | Fundam Res | 2025 | 40528978 | PubTator, text mining | PubMed |
| Biological and metabolomic insights into RACGAP1-mediated growth and progression of clear cell renal cell carcinoma. | Am J Physiol Cell Physiol | 2025 | 40522863 | PubTator, text mining | PubMed |
| Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients. | PLoS One | 2025 | 40504854 | PubTator, text mining | PubMed |
| Investigating the Genetic Links Between Immune Cell Profiles and Bladder Cancer: A Multidisciplinary Bioinformatics Approach. | Biomedicines | 2025 | 40427030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55165/papers?page=3